Analysis of RNA-seq and miRNA-seq data from several NSCLC patients suggested that alterations in WNT9A might impact cancer progression by affecting the interference between lncRNAs, miRNAs, and mRNAs (55). The gene discussed is WNT9A; the disease is cancer.